Matching articles for "diet pill"
Issue 1263 · June 18, 2007 Free
In Brief: Orlistat OTC for Weight Loss

The FDA has approved over-the-counter (OTC) sale of the weight-loss drug orlistat ( Xenical – Roche) 1 as alli (GlaxoSmithKline), to be used in combination with a reduced-calorie, low-fat diet. Orlistat…

Med Lett Drugs Ther. 2007 Jun 18; 49(1263):49
The FDA has approved over-the-counter (OTC) sale of the weight-loss drug orlistat ( Xenical – Roche) 1 as alli (GlaxoSmithKline), to be used in combination with a reduced-calorie, low-fat diet. Orlistat binds to gastric and pancreatic lipases, preventing absorption of about 30% of dietary fat with the 120-mg prescription dose, and 25% with the 60-mg OTC dose. A 16-week controlled trial of the OTC dose (60 mg 3 times daily with meals) in overweight, not obese, patients (average BMI 26.8) on a reduced-calorie, low-fat diet found that patients taking the drug lost 1.15 kg more than those taking placebo. 2 Orlistat causes flatulence with oily spotting, loose stools, fecal urgency and occasional incontinence in 20-40% of patients on a low-fat diet; these effects presumably would be more frequent and more severe with a higher fat intake or self-prescription of higher-thanrecommended doses. The drug also interferes with absorption of fat-soluble vitamins (A, D, E, K); the manufacturer recommends that patients also take a multivitamin supplement at bedtime. Orlistat can increase the anticoagulant effect of warfarin and may interfere with the absorption of other drugs. A “starter pack” of 90 capsules of alli (60 mg each) costs $62.99, compared to $224.64 for 90 capsules of Xenical (120 mg each). 3 1. Orlistat for obesity. Med Lett Drugs Ther 1999; 41:55. 2. JW Anderson et al. Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: a 16 week, double-blind, placebo-controlled trial. Ann Pharmacother 2006; 40:1717. 3. Cost based on information from drugstore.com (June 11, 2007). Download U.S. English